Copyright
©The Author(s) 2024.
World J Gastrointest Oncol. Feb 15, 2024; 16(2): 273-286
Published online Feb 15, 2024. doi: 10.4251/wjgo.v16.i2.273
Published online Feb 15, 2024. doi: 10.4251/wjgo.v16.i2.273
Figure 2 Concepts of hepatocellular carcinoma immunotherapy, immunotherapy combination therapy, and related trials in recent years.
HCC: Hepatocellular carcinoma; CAR-T: Chimeric antigen receptor T cells; VEGF: Vasoactive endothelial growth factor.
- Citation: Pan D, Liu HN, Qu PF, Ma X, Ma LY, Chen XX, Wang YQ, Qin XB, Han ZX. Progress in the treatment of advanced hepatocellular carcinoma with immune combination therapy. World J Gastrointest Oncol 2024; 16(2): 273-286
- URL: https://www.wjgnet.com/1948-5204/full/v16/i2/273.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v16.i2.273